Valuation: Coeptis Therapeutics

Market Cap 102M 89.76M 84.88M 76.99M 145M 9.8B 145M 1.02B 393M 5B 383M 375M 16.06B P/E 2024
-1.08x
P/E 2025 -5.06x
Enterprise Value 95.98M 84.41M 79.82M 72.4M 136M 9.21B 137M 956M 369M 4.7B 360M 353M 15.11B EV / Sales 2024
-
EV / Sales 2025 51.4x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day+23.02%
Current month-71.46%
6 months-56.34%
Current year-67.16%
Current year 3.66
Extreme 3.655
17.27
1 year 3.66
Extreme 3.655
21.41
3 years 2.31
Extreme 2.31
27.6
5 years 2.31
Extreme 2.31
428.4
10 years 2.31
Extreme 2.31
428.4

Financials

2024 2025
Net sales - 1.36M 1.2M 1.13M 1.03M 1.93M 131M 1.94M 13.57M 5.24M 66.77M 5.12M 5.01M 215M
Net income -9.81M -8.63M -8.16M -7.4M -13.9M -942M -13.98M -97.72M -37.74M -481M -36.84M -36.05M -1.54B -11.92M -10.48M -9.91M -8.99M -16.88M -1.14B -16.98M -119M -45.83M -584M -44.74M -43.77M -1.88B
Net Debt 866K 762K 720K 653K 1.23M 83.14M 1.23M 8.63M 3.33M 42.43M 3.25M 3.18M 136M -6.08M -5.35M -5.06M -4.59M -8.62M -584M -8.67M -60.56M -23.39M -298M -22.83M -22.34M -957M
Logo Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and advanced robotic process automation capabilities. Its Coeptis Technologies division is focused on diversifying and enhancing its growth potential. Its subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Employees
5
Sector
-
Date Price Change Volume
26-09-28 US$4.705 +24.47% 485,218
26-09-25 US$3.780 +1.89% 560,828
26-09-24 US$3.710 +25.34% 908,903
26-09-23 US$2.960 +6.09% 321,220
26-09-22 US$2.790 +5.68% 275,088
  1. Stock Market
  2. Stocks
  3. COEP Stock